CVR number 32342124
Industry 86.9020 Other human health activities

RØDOVRE CENTRUMS FYSIOTERAPI ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  0.6% 0.6% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 1.8% 2.3% 1.3%  
Credit score (0-100)  0 0 73 66 82  
Credit rating  N/A N/A A BBB A  
Credit limit (kDKK)  0.0 0.0 1.0 0.0 34.2  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,670 1,848 1,962  
EBITDA  0.0 0.0 354 151 446  
EBIT  0.0 0.0 310 44.0 341  
Pre-tax profit (PTP)  0.0 0.0 289.9 69.6 332.8  
Net earnings  0.0 0.0 215.5 54.7 256.0  
Pre-tax profit without non-rec. items  0.0 0.0 290 69.6 333  
 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 401 340 235  
Shareholders equity total  0.0 0.0 1,214 1,268 1,524  
Interest-bearing liabilities  0.0 0.0 332 306 0.0  
Balance sheet total (assets)  0.0 0.0 1,846 1,914 1,858  
Net Debt  0.0 0.0 -587 -522 -595  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,670 1,848 1,962  
Gross profit growth  0.0% 0.0% 0.0% 10.7% 6.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 1,846 1,914 1,858  
Balance sheet change%  0.0% 0.0% 0.0% 3.7% -2.9%  
Added value  0.0 0.0 354.4 88.0 446.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 357 -169 -210  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 18.6% 2.4% 17.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 17.1% 3.7% 18.2%  
ROI %  0.0% 0.0% 20.2% 4.4% 22.0%  
ROE %  0.0% 0.0% 17.8% 4.4% 18.3%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 65.7% 66.3% 82.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -165.7% -345.4% -133.4%  
Gearing %  0.0% 0.0% 27.3% 24.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 15.1% 0.0% 7.0%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 1.8 2.0 4.0  
Current Ratio  0.0 0.0 1.8 2.0 4.0  
Cash and cash equivalent  0.0 0.0 918.9 827.9 595.3  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 519.3 609.7 973.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0